Roivant Sciences Ltd.

Last updated September 27, 2026

Organization details

Legal name
Roivant Sciences Ltd.
Ownership
Public
Status
Active
Headquarters country
United Kingdom
Ticker symbol
ROIV
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001635088

Board of directors

Chief executives

Matthew Gline · CEO
Dates unknown

Board connections

4 of this board's directors also sit on 4 other boards.

Network of Roivant Sciences Ltd.'s board connections Arbutus Biopharma Corporation Arbutus Biopharma Corp... BridgeBio Pharma Inc. BridgeBio Pharma Inc. Nautilus Biotechnology Inc. Nautilus Biotechnology... Tenet Healthcare Corporation Tenet Healthcare Corpo... James C. Momtazee James C. Momtazee Keith S. Manchester Keith S. Manchester Meghan Fitzgerald Meghan Fitzgerald Melissa B. Epperly Melissa B. Epperly Roivant Sciences Ltd.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 20, 2024 Pulik Richard Officer (CFO) Shares withheld for tax −2,129 $10.80 $22,993
Jun 20, 2024 Rakhi Kumar Officer (Chief Accounting Officer) Shares withheld for tax −3,087 $10.80 $33,340
Jun 20, 2024 Venker Eric Officer (President & COO) Shares withheld for tax −10,945 $10.80 $118,206
Jun 20, 2024 Matthew Gline Director, Officer (CEO) Shares withheld for tax −10,945 $10.80 $118,206
May 28, 2024 Pulik Richard Officer (CFO) Shares withheld for tax −2,341 $10.83 $25,353
May 20, 2024 Venker Eric Officer (President & COO) Shares withheld for tax −16,003 $11.37 $181,954
May 20, 2024 Rakhi Kumar Officer (Chief Accounting Officer) Shares withheld for tax −1,363 $11.37 $15,497
May 20, 2024 Matthew Gline Director, Officer (CEO) Shares withheld for tax −10,945 $11.37 $124,445
Apr 28, 2024 Pulik Richard Officer (CFO) Shares withheld for tax −2,340 $11.03 $25,810
Apr 24, 2024 Ilan Oren Director Grant or award +2,121 — —
Apr 24, 2024 James C. Momtazee Director Grant or award +1,490 — —
Apr 24, 2024 Meghan Fitzgerald Director Grant or award +1,261 — —
Apr 24, 2024 Melissa B. Epperly Director Grant or award +1,146 — —
Apr 24, 2024 Ilan Oren Director Shares withheld for tax −54 $10.90 $589
Apr 24, 2024 James C. Momtazee Director Shares withheld for tax −293 $10.90 $3,194

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.